¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Trance and possession disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gray matter (nuclei and columns)
    ȸ»öÁú(½Å°æÇÙ°ú ½Å°æ±âµÕ)
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • hand and foot disease
    ¼ö Á· Áúȯ£¨â¢ðëòðü´£©£¬¼Õ ¹ß º´, ¼ö Á· º´ (â¢ðëÜ»).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ)
  • heat and acetic acid test
    °¡¿Â¾Æ¼¼Æ®»ê½ÃÇè (¹ý)(ʥ计­ß«ãËúÐÛö).
  • hereditary motor and sensory neuropathy
    À¯Àü¼º¿îµ¿ °¨°¢½Å°æº´Áõ
  • incision and drainage
    Àý°³¹è³ó(ü°³¹è³ó).
  • personality, anxious and fearful
    ºÒ¾È°øÆ÷¼º ÀΰÝ
  • pharmacy and therapeutic committee
    ¾à»çÀÇ·áÀ§¿øÈ¸(ËâË×ËöËíËôËôÌ·) º´¿ø(ËÓ Ëô)ÀÇ .
  • pneumocyte, types i and ii
    ÆóÆ÷¼¼Æ÷(øËøàá¬øà), IÇü°ú IIÇü
  • porokeratotoic eccrine ostial and dermal duct nevus
    ÇѰø°¢È­Áõ¼º ¿¡Å©¸°±¸¸Û ¹× ÁøÇǰü¸ð¹Ý
  • positional and postural vertigo
    µÎÀ§ ¹× üÀ§ º¯È¯(¼º) Çö±â
  • pruritic urticarial papules and plaqes of pregnany
    ÀӽŠ¼Ò¾ç¼º µÎµå·¯±â¼º ±¸Áø ¹× ÆÇ
  • pulmonary congestion and edema
    Æó¿ïÇ÷(øËê¦úì) ¹× ÆóºÎÁ¾(øËÝ©ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • movement disorders
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • neuroleptic-induced disorders
  • nutritional disorders
    ¿µ¾çÀÌ»ó<Àå¾Ö>.
  • olfactory disorders
    Èİ¢Àå¾Ö
  • organic voice disorders
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DSM-III-R Diagnostic and Statistical Manual of Mental Disorders [of APA], third edition, revised
DSM-IV Diagnostic and Statistical Manual of Mental Disorders [of APA], fourth edition
SADS Schedule for Affective Disorders and Schizophrenia
SADS-C Schedule for Affective Disorders and Schizophrenia-Change
SADS-L Schedule for Affective Disorders and Schizophrenia-Lifetime
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EDI Eating Disorders Inventory
ICSD International Classification of Sleep Disorders
IDD Iodine Deficiency Disorders
LBD Low-back disorders
NMD Neuronal migration disorders
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • heating and cooling temperature-place-time profile
    °¡¿­ ¹× ³Ã°¢ ¿Âµµ-À§Ä¡-½Ã°£ Çü
  • Hines and Brown test
    ÇÏÀνº ºê¶ó¿î ½ÃÇè
    ¾óÀ½ ¹°¿¡ ÇÑÂÊ ¼ÕÀ» ´ã±×°í Ç÷¾ÐÀÇ ¹ÝÀÀÀ» ÃøÁ¤ÇÑ´Ù °úµµ·Î Ç÷¾ÐÀÌ »ó½ÂÇϸé ÀáÀ缺 °íÇ÷¾Ð »óŸ¦ ¶æÇÑ´Ù.
  • incision and drainage
    Àý°³ ¹è³ó
    »óó, ±Ë¾ç, °øµ¿¿¡¼­ ¾×ü³ª ¹è¼³¹°À» ü°èÀûÀ¸·Î ¹èÃâ½ÃŰ´Â °Í.
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
    ¿µ¾Æ±â·ÎºÎÅÍ »çÃá±â±îÁöÀÇ »ç¶÷.
  • inlay with pin and post
    À¯Á¤ Àη¹ÀÌ
    Àη¹ÀÌü¿¡ Æ÷½ºÆ® ¶Ç´Â ÇÉÀ» º´¿ëÇÏ¿© º¸Áö·ÂÀ» °­È­½ÃŲ °Í.
  • lateral and protrusive excursion
    Ãø¹æ ¹× Àü¹æ Á¢ÃË ¿îµ¿
  • lateral cord and associated anterior cornual syndrome
    Ãø»è µ¿Ãø Àü°¢ ÁõÈıº
  • maternity and infant hygiene
    ¸ð¼º ¿µ¾Æ À§»ý, ¸ð¼º ¿µ¾Æ À§»ýÇÐ
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú ¿Âµµ°è
  • metal backing with pin and post
    À¯Á¤ ¼³¸éÆÇ
    ÀüÄ¡ºÎ °¡°øÄ¡ÀÇ ¼³¸é ¹× ¼Õ½ÇÃø ÀÎÁ¢¸éÀÇ ÀϺθ¦ ÇǺ¹ÇÏ´Â ¼³¸éÆÇ¿¡
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • mortar and pestle
    À¯¹ß°ú À¯ºÀ
  • myoclonic epilepsy and raggedred fibers
    °£´ë ±ÙÀ° °æ·Ã¼º °£Áú
  • normocytic and normochromic anemia
    Á¤ÀûÇ÷±¸¼º ºóÇ÷
  • one : À¯±âÈ­Çп¡¼­ ÄÉÅæÀÌ ÀÖÀ½À» ³ªÅ¸³»´Â Á¢¹Ì¾î.

    one and one-half syndrome

    1°ú 1/2 ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
child nutrition disorders Malnutrition, occurring in children ages 2 to 12 years, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
peroxisomal disorders A heterogeneous group of inherited metabolic disorders in which peroxisomes are either defective or totally lacking and/or there is a dysfunction of single or multiple peroxisomal enzymes. Patients show metabolic defects in all the major biosynthetic peroxisomal pathways, especially failure to synthesise ether lipids, or to oxidise long-chain fatty acids, and accumulate bile acid precursors. The disorders include zellweger syndrome, infantile refsum disease, rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic), and hyperpipecolic acidemia.
(12 Dec 1998)
personality disorders A major deviation from normal patterns of behaviour.
(12 Dec 1998)
growth disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth.
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • safe and sound
    ¹«»çÈ÷
  • touch-and-go
    ¸÷½Ã ºÒ¾ÈÇÑ
  • up-and-down
    ¿À¸£³»¸®´Â
  • Box and Cox
    µ¿½Ã¿¡´Â ¾È ³ªÅ¸³ª´Â µÎ »ç¶÷;ÇÑ ¿ªÇÒÀ» ±³´ë·Î ÇÏ´Â µÎ »ç¶÷
  • C and (&) W
    country-and-western
  • Damon and Pythias
    ´Ù¸Õ°ú ÇÇÆ¼¾Æ½º(¿¾ ±Û½º¿¡¼­ ¸ñ¼ûÀ» °É°í ¸Í¼¼¸¦ ÁöŲ µÎ Ä£±¸);µÑµµ ¾ø´Â Ä£±¸;ÀýÄ£ÇÑ Ä£±¸;¸·¿ªÇÑ ¹þ ', '
  • Daphnis and Chloe
    ´ÙÇÁ´Ï½º¿Í Ŭ·Î¿¡(2-3¼¼±â°æ ±×¸®½ºÀÇ ¸ñ°¡ÀûÀÎ À̾߱⠼ÓÀÇ ¼øÁøÇÑ ¿¬Àεé)
  • Darby and Joan
    (¹Î¿äÁßÀÇ ³ëºÎºÎ¿¡¼­);ÀÇÁÁÀº ´ÄÀº ºÎºÎ
  • Dark and Bloody Ground
    (¹Ì)KentuckyÁÖÀÇ º°¸í(ÃʱâÀÇ Àεð¾ð°úÀÇ ÀüÅõ¿Í °ü·ÃµÈ ȣĪ)
  • E.and P.
    extraordinary and plenipotentiary Ư¸í Àü±ÇÀÇ
  • Economic and Social Council
    =ECOSOC
  • Food and Agriculture Organization
    (À¯¿£) ½Ä·® ³ó¾÷ ±â±¸
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
  • Foreign and Commonwealth Office
    ¿Ü¹« ¿¬¹æ¼º
  • Gog and Magog
    °î°ú ¸¶°î(»çÅÁ¿¡ ¹ÌȤµÇ¾î ÇÏ´Ã ³ª¶ó¿¡ ´ëÇ×ÇÏ´Â µÎ³ª¶ó)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á